Acutus Medical (AFIB) Competitors $0.08 +0.01 (+14.29%) (As of 09/19/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AFIB vs. INBS, NURO, NXL, BTCY, NUVO, AEMD, BSGM, POAI, STSS, and VEROShould you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include Intelligent Bio Solutions (INBS), NeuroMetrix (NURO), Nexalin Technology (NXL), Biotricity (BTCY), Holdco Nuvo Group D.G (NUVO), Aethlon Medical (AEMD), BioSig Technologies (BSGM), Predictive Oncology (POAI), Sharps Technology (STSS), and Venus Concept (VERO). These companies are all part of the "medical equipment" industry. Acutus Medical vs. Intelligent Bio Solutions NeuroMetrix Nexalin Technology Biotricity Holdco Nuvo Group D.G Aethlon Medical BioSig Technologies Predictive Oncology Sharps Technology Venus Concept Intelligent Bio Solutions (NASDAQ:INBS) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment, valuation and community ranking. Does the MarketBeat Community favor INBS or AFIB? Acutus Medical received 12 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users. CompanyUnderperformOutperformIntelligent Bio SolutionsN/AN/AAcutus MedicalOutperform Votes1232.43% Underperform Votes2567.57% Is INBS or AFIB more profitable? Acutus Medical has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -354.86%. Acutus Medical's return on equity of -105.86% beat Intelligent Bio Solutions' return on equity.Company Net Margins Return on Equity Return on Assets Intelligent Bio Solutions-354.86% -210.36% -89.33% Acutus Medical N/A -105.86%-10.79% Does the media refer more to INBS or AFIB? In the previous week, Acutus Medical had 2 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 4 mentions for Acutus Medical and 2 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 0.47 beat Acutus Medical's score of 0.13 indicating that Intelligent Bio Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intelligent Bio Solutions 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Acutus Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals believe in INBS or AFIB? 33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 0.3% of Intelligent Bio Solutions shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has preferable valuation and earnings, INBS or AFIB? Intelligent Bio Solutions has higher earnings, but lower revenue than Acutus Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntelligent Bio Solutions$2.83M2.15-$10.63M-$38.91-0.05Acutus Medical$7.16M0.29-$81.66MN/AN/A Do analysts recommend INBS or AFIB? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AAcutus Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummaryAcutus Medical beats Intelligent Bio Solutions on 8 of the 11 factors compared between the two stocks. Ad InvestorPlace“I’ll Give You the Knowledge and Confidence You Need to Make Your First Options Trade in Five Days or Less… Guaranteed!”Starting Monday, September 23 — a veteran 25-year Chicago Options Exchange market-maker will show you his UOA options secret that could help you consistently target gains of 126%… 245%… even 463% or more… Often in 30 days or less… No matter what the market is doing right now.Go here for the full details now. Get Acutus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AFIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFIB vs. The Competition Export to ExcelMetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.11M$4.17B$5.68B$8.49BDividend YieldN/A46.03%4.95%4.07%P/E RatioN/A14.22146.4318.66Price / Sales0.2969.641,657.4872.43Price / CashN/A50.9937.1731.48Price / Book-2.374.394.934.59Net Income-$81.66M$3.15M$115.07M$225.14M7 Day PerformanceN/A0.92%6.53%5.65%1 Month PerformanceN/A9.30%7.26%6.01%1 Year PerformanceN/A30.34%31.76%14.06% Acutus Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INBSIntelligent Bio Solutions0.4501 of 5 stars0.45 / 5 stars$2.53+2.0%N/A-87.2%$7.89M$2.83M-0.0710Gap DownNURONeuroMetrix0.2239 of 5 stars0.22 / 5 stars$3.81-5.9%N/A-30.0%$7.66M$4.38M-0.6020Analyst ForecastNews CoverageNXLNexalin Technology0.7283 of 5 stars0.73 / 5 stars$0.68+4.4%N/A+45.5%$7.22M$150,159.00-1.033Gap UpBTCYBiotricity0 of 5 stars0.00 / 5 stars$0.32-2.1%N/A-85.5%$6.93M$12.06M-0.2440News CoverageGap DownNUVOHoldco Nuvo Group D.G0 of 5 stars0.00 / 5 stars$0.17-23.6%N/AN/A$5.65M$180,000.000.00N/APositive NewsAEMDAethlon Medical2.9754 of 5 stars2.98 / 5 stars$0.36-5.2%$7.00+1,843.4%-85.8%$5.01M$570,000.00-0.0810News CoverageBSGMBioSig Technologies0 of 5 stars0.00 / 5 stars$0.30-2.1%N/A-93.4%$4.27M$27,000.000.0050Gap DownPOAIPredictive Oncology2.6686 of 5 stars2.67 / 5 stars$0.90-1.2%$3.00+231.7%-71.7%$3.71M$1.75M-0.2530News CoverageSTSSSharps Technology0.7313 of 5 stars0.73 / 5 stars$0.23+4.5%N/A-68.2%$3.60MN/A-0.383News CoverageVEROVenus Concept1.9692 of 5 stars1.97 / 5 stars$0.50+0.1%N/A-78.0%$3.18M$69.81M-0.07410News CoveragePositive News Related Companies and Tools Related Companies: INBS Competitors NURO Competitors NXL Competitors BTCY Competitors NUVO Competitors AEMD Competitors BSGM Competitors POAI Competitors STSS Competitors VERO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AFIB) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget ChatGPT: Follow the AI Retirement PlaybookEveryone’s talking about AI right now, but I’ve been talking about it for years. Follow this two-part playb...Brownstone Research | SponsoredDump Nvidia, Apple, and Tesla Before It’s Too LateThe financial world is on high alert. Billionaires like Warren Buffett, Jeff Bezos, and Elon Musk are dumpi...InvestorPlace | SponsoredNew September Stock WarningSeptember is the most volatile month of the year for stocks. And after the brutal tech selloff, one Wall St...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
